ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Clinical Practice Session

Controversies at the Cutting Edge of AKI

October 25, 2020 | 02:30 PM - 04:30 PM

Location: Live-Streamed

Session Description

This session features a diverse set of lectures, each touching on a contemporary controversy in the field of AKI.  

Learning Objective(s)

  • Describe the limitations of designating all increases in serum creatinine as AKI
  • Explain the epidemiology of contrast-induced AKI and strategies for its prevention
  • Discuss the status of AKI biomarkers and how they may shape clinical practice
  • Appraise the benefits of balanced crystalloids in the prevention of AKI among hospitalized patients

Learning Pathway(s)

  • Acute Kidney Injury

Moderators

  • Josee Bouchard, MD
  • Raymond K. Hsu, MD

Presentations

  • Much Ado About Nothing: Should All Increases in Serum Creatinine Cause Us to Worry?
    02:30 PM - 03:00 PM
    Steven G. Coca, DO, MS 
  • Biomarkers in AKI: Will They Ever Be Ready for Prime Time?
    03:00 PM - 03:30 PM
    Sherry Mansour, MD, MS
  • Does Contrast-Induced AKI Exist, and If It Does, How Can We Prevent It?
    03:30 PM - 04:00 PM
    Steven D. Weisbord, MD, FASN
  • Balanced Crystalloid Solutions: The New Standard of Care in Hospitalized Patients?
    04:00 PM - 04:30 PM
    Edward D. Siew, MD, MS